TherapeuticsMD, Inc. — Director's Dealing 2021

Jul 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2021-07-01

Reporting Person: Naughton Gail K (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-01	Restricted Stock Units	$0	A	99174	Acquired		Common Stock (99174)	Direct

Footnotes

F1: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on July 1, 2022.